NCT07313384Active, not recruiting
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 1 Dec 2025
- Start date
- 11 Feb 2026
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- University of South Carolina
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT07313384
What you commit to
- Study type: Observational
- Planned participants: 50
- From 11 Feb 2026 to the primary completion date, 1 Nov 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Already began the GLP-1 medication
Other
- Have medical concerns making participation unsafe
Who the study is looking for
- Adults aged 18 and older
- Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
- Has regular access to a smartphone and internet to complete short surveys and food recalls online
- Willing to sign informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University South Carolina Coordinator of this site? Confirm its status | Columbia | United States | Unknown status |
| Prisma Health Weight Management Institute Coordinator of this site? Confirm its status | Greenville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.